Physiology of Volition Studied With Nerve Block
2 other identifiers
observational
N/A
1 country
1
Brief Summary
Background: \- The experience of volition that accompanies voluntary movement can be divided into the sense of will, or deciding to move, and the sense of agency, or feeling that the movement just made was self-generated. Very little is known regarding the neurological origin of this sense of volition. Previous research has shown that a particular part of the brain, the parietal lobe, is involved in our inner sense that we control the movements we make. Researchers are interested in determining if this sense relies on sensory information from moving fingers reaching the parietal lobe. Objectives: \- To determine the brain regions responsible for the sense of volition and the associated sense of agency. Eligibility: \- Healthy right-handed individuals between 18 and 55 years of age. Design:
- The study will involve a screening visit and two testing visits. The screening visit will last 30 minutes to 1 hour, and the testing visits will each last 3 to 4 hours.
- Participants will be screened with a physical examination and medical history.
- At each testing visit, participants will have a brain magnetic resonance imaging (MRI) scan, electroencephalography (EEG), and electromyography (EMG). The MRI scan and EEG will be done during a movement task that involves the thumb, second finger, and fifth finger of one hand. EMG will be used to monitor movements and muscle activity.
- During the second testing visit, participants will receive a nerve block using anesthetic, followed by the MRI, EEG, EMG and movement task. The nerve block will temporarily numb and prevent the movement of parts of the hand and fingers.
- After the MRI scan and EEG recording, participants will be asked to rate how much control they felt they had over choosing whether to move, and how much control they felt they had in actually making the movements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2010
CompletedFirst Submitted
Initial submission to the registry
June 11, 2010
CompletedFirst Posted
Study publicly available on registry
June 14, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
January 4, 2012
CompletedJuly 2, 2017
January 4, 2012
June 11, 2010
June 30, 2017
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Healthy right-handed subjects ranging from 18 to 55 will be included. All subjects should have a valid Clinical Center Medical Record Number.
You may not qualify if:
- Healthy subjects younger than 18 years and older than 55 will be excluded.
- Subjects with MRI findings consistent with organic brain lesions such as brain tumors, stroke, trauma or AVMs will be excluded.
- Subjects with active significant medical or neurological disorders, or active Axis I psychiatric disorders, or requiring continuous treatment with drugs that affect the central nervous system will be excluded.
- We will not include pregnant women because safety of high magnetic field to fetus is not established.
- Subjects allergic to local anesthetics such as bupivacaine will be excluded.
- Subjects unable to have an MRI due to claustrophobia or contraindications to MR scanning will be excluded.
- Subjects who are left-handed will be excluded.
- Subjects will be excluded who are taking anticoagulant or antiplatelet medications such as warfarin, heparin, clopidogrel, ticlopidine, or fondiparinux, or vitamin E in amounts greater than 1600 IU per day.
- If subjects are taking daily aspirin therapy, this must be held for 7 days prior to the nerve block. If subjects are taking daily NSAIDs, these must be held for 12 hours prior to the nerve block. If these medications cannot be held for these periods, the subject will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
Related Publications (3)
Blakemore SJ, Oakley DA, Frith CD. Delusions of alien control in the normal brain. Neuropsychologia. 2003;41(8):1058-67. doi: 10.1016/s0028-3932(02)00313-5.
PMID: 12667541BACKGROUNDLibet B, Gleason CA, Wright EW, Pearl DK. Time of conscious intention to act in relation to onset of cerebral activity (readiness-potential). The unconscious initiation of a freely voluntary act. Brain. 1983 Sep;106 (Pt 3):623-42. doi: 10.1093/brain/106.3.623.
PMID: 6640273BACKGROUNDDeecke L, Kornhuber HH. An electrical sign of participation of the mesial 'supplementary' motor cortex in human voluntary finger movement. Brain Res. 1978 Dec 29;159(2):473-6. doi: 10.1016/0006-8993(78)90561-9. No abstract available.
PMID: 728816BACKGROUND
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
Study Record Dates
First Submitted
June 11, 2010
First Posted
June 14, 2010
Study Start
June 1, 2010
Study Completion
January 4, 2012
Last Updated
July 2, 2017
Record last verified: 2012-01-04